Archives
232 / 652
Premium
Portfolio Changes: [stock] enters The Long Term Portfolio and add a little more of [stock]
Our long term portfolio is performing reasonably, even though there was this whole Brexit thing today. Sudarshan, Supreme Petro, KRBL and Aegis Logistics ...
Premium
Momentum Portfolio: One New Position and Remarkably, Stocks Are Holding Up
A quick note to summarize a few changes in the Momentum Portfolio. • Added Finolex Industries (FINPIPE) at 408. This has been an outlier in the ...
General
On Slack: GST blueprint, B/F/REXIT impact, Inflation doves, Booze express, The Inevitable Exit, Commodity Options and much more….
The Slack Discussions The Slack group at Capital Mind Premium has been extremely active and if you haven’t been there (Premium subscribers only), pop us a ...
Stocks
Narayana Murthy’s Catamaran Ventures enter Wonderla Holidays with 4.37 lakh shares
Wonderla Holidays are one of the largest amusement park operators in India with over 16 years of successful operations. The company operates three largest ...
Stocks
Sun Pharma Announces Buyback of Equity Shares – 7.5 million shares at Rs. 900 a piece
Sun Pharmaceutical Industries announced that, the Board of Directors of the Company at its meeting held on June 23, 2016 approved the buyback of its ...
Stocks
Mahanagar IPO Subscribed 64 times; Rs. 63,800 crore blocked from market
Mahanagar Gas IPO is over in a big way. The IPO subscription had been mind blowing at 64.48 times. But whats the impact of over subscription on the market? ...
Stocks
Unichem Laboratories receives ANDA approval for Donepezil Hydrochloride Tablets
Unichem Laboratories is a specialty pharmaceutical company with a large basket of branded generics in India and several other markets across the world. ...
General
Hawa Badlo abhiyaan – Pilot Programme to run two wheelers on CNG
In a major step to curb rising air pollution in Indian cities, the centre has launched first of its kind Pilot Programme in the country to run two wheelers on ...
Stocks
Biocon receives approval from Drug Controller General of India for the first ever clinical trial of a siRNA therapy
Biocon – one of the largest emerging global biopharmaceutical enterprise (has a rich pipeline of Biosimilars and Novel Biologics at various stages of ...
Charts & Analysis
Options: Is there a #Brexit play? Uncle Theta explores.
The event is upon us and India VIX – a measure of uncertainty in NIFTY’s options market – reached adulthood today, closing above 18. If you ...
